An interactive mHealth app for better glycemic control in families of young kids with T1D
一款交互式 mHealth 应用程序,可帮助患有 T1D 的幼儿家庭更好地控制血糖
基本信息
- 批准号:9036786
- 负责人:
- 金额:$ 101.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-20 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:3 year old5 year old6 year oldAcademyAddressAdherenceAdoptedAdoptionAgeBehaviorBehavior TherapyBehavioralCaringCharacteristicsChildChild RearingChildhoodClinicClinical TrialsCognitive deficitsDataDevelopmentDiabetes MellitusDiagnosisDietDietary InterventionDiseaseEatingEducationEducational process of instructingElectronic MailFaceFamilyFrightGlucoseGlycosylated hemoglobin AGoalsHealthHealth Services AccessibilityHypoglycemiaIncidenceInsulinInsulin-Dependent Diabetes MellitusInternetInterventionLeadLearningMethodsMorbidity - disease rateOutcomeParentsPatientsPhysical activityProblem behaviorProgress ReportsPublic HealthPublishingRandomizedReadinessRegimenReportingResearchResearch DesignRiskSchemeSelf CareSeriesStagingStressSymptomsTechnologyTestingTimeTreatment ProtocolsUrsidae FamilyWaiting ListsWorkage groupbasedesigndiabetes managementexternalizing behaviorflexibilityglycemic controlhigh riskimprovedinnovationinsulin sensitivityiterative designmHealthmacrovascular diseasemortalitypersonalized medicineprogramspublic health relevancerandomized trialresponseskillssuccesstargeted treatmenttherapy developmenttreatment adherence
项目摘要
DESCRIPTION (provided by applicant): To achieve good glycemic control families of young children with type 1 diabetes mellitus (T1D) must adhere to a well-designed and rigorous treatment regimen. Unfortunately, our research program has published data showing that many young children have glucose levels that exceed pediatric targets and show a high rate of glucose variability. By virtue of their age, size, and developmental status, young children with T1D face many unique challenges to adherence (i.e., increased insulin sensitivity, unpredictable physical activity and food intake, oppositional behavior). We've also identified other barriers to good glycemic control, including mealtime behavior problems, child defiance, and parental stress and fear of hypoglycemia. In order to address these barriers and improve children's glycemic control, we created and tested a parent-based behavioral-nutrition intervention, BEST MEALS. Initial results suggest a mean decrease of 26 mg/dl in young children's daily glycemic levels without increasing hypoglycemia. Building on this success and in response to parents' requests for more assistance delivered in a flexible format that matches their busy lives, in this new study we propose to substantially advance our BEST MEALS intervention through three new design features: 1) new treatment content addressing additional domains of T1D self-care (i.e., insulin use, parental hypoglycemia fear), 2) new child-focused and developmentally targeted treatment content allowing for a family-focused approach and learning activities appropriately matched to each young child's stage of development and readiness to engage in learning about T1D (i.e., helping out with T1D self-care), and 3) a mHealth delivery format using video-based microlectures accessible via the internet to increase scalability and personalized weekly progress reports emailed to families to reinforce the positive changes they make to their child's T1D self-care and glycemia. Thus, our current aims include: 1) to develop DIPPer Academy (Diabetes Information for Parents of Preschoolers), a family-focused mHealth behavioral intervention to promote glycemic control and adherence in young children, 2) to assess relevance, engagement, feasibility, and acceptability of DIPPer Academy through a family-centered iterative design scheme, and 3) to explore the initial efficacy of DIPPer Academy using a randomized, wait-list control design. The project is significant because it directly addresses the limited availability of developmentally-targeted behavioral interventions for families of young children with T1D and proposes to use mHealth to deliver DIPPer Academy thereby making it easier for families to access the treatment and easier to disseminate to other diabetes centers. It is innovative in its plan to include child- focused and developmentally-targeted treatment content in addition to parent treatment content, two treatment tracks based on child age (Li'l DIPPer for children <3 years old and Big DIPPer for 3-5 year olds), and in its plan to use a mHealth delivery format. We expect DIPPer Academy, developed and pilot-tested in this study, will have public health significance by improving health outcomes for young children with T1D.
描述(由申请人提供):为了实现 1 型糖尿病 (T1D) 幼儿的良好血糖控制,家庭必须坚持精心设计和严格的治疗方案,不幸的是,我们的研究项目公布的数据显示,许多幼儿患有糖尿病。血糖水平超过儿科目标并表现出较高的血糖变异率 由于年龄、体型和发育状况,患有 T1D 的幼儿面临着许多独特的依从性挑战(即胰岛素敏感性增加、不可预测的体力活动和食物)。我们还发现了良好血糖控制的其他障碍,包括进餐时间行为问题、儿童反抗以及父母的压力和对低血糖的恐惧。为了解决这些障碍并改善儿童的血糖控制,我们创建并测试了这些障碍。基于家长的行为营养干预,BEST MEALS 的初步结果表明,在这一成功的基础上,幼儿的每日血糖水平平均降低了 26 毫克/分升,并且没有增加低血糖发生率。为了满足家长要求以灵活的形式提供更多帮助以适应他们忙碌生活的要求,在这项新研究中,我们建议通过三个新的设计特点大幅推进我们的“最佳膳食”干预措施:1) 针对 T1D 自我护理的其他领域的新治疗内容(即胰岛素的使用、父母对低血糖的恐惧),2) 新的以儿童为中心和以发展为目标的治疗内容,允许采取以家庭为中心的方法和学习活动,与每个幼儿的发展阶段和学习 T1D 的准备情况适当匹配(即帮助 T1D 自我护理),以及 3) 移动医疗交付形式,使用可通过互联网访问的基于视频的微讲座来提高可扩展性,并通过电子邮件向家庭发送个性化的每周进展报告,以强化他们对孩子的 T1D 做出的积极改变因此,我们当前的目标包括:1) 开发 DIPPer Academy(学龄前儿童家长糖尿病信息),这是一种以家庭为中心的移动健康行为干预措施,旨在促进血糖控制和血糖控制。幼儿的依从性,2) 通过以家庭为中心的迭代设计方案评估 DIPPer Academy 的相关性、参与度、可行性和可接受性,以及 3) 使用随机、等待名单控制设计探索 DIPPer Academy 的初步功效。该项目意义重大,因为它直接解决了 T1D 幼儿家庭针对发育的行为干预措施的有限性,并提议利用移动健康来提供 DIPPer Academy,从而使家庭更容易获得治疗并更容易传播与其他糖尿病中心相比,它的计划具有创新性,除了家长治疗内容外,还包括以儿童为中心和针对发育的治疗内容,根据儿童年龄提供两种治疗轨道(针对<3岁儿童的Li'l DIPPer和Big DIPPer)。 3-5 岁儿童),并计划使用 mHealth 交付形式,我们预计在本研究中开发和试点测试的 DIPPer Academy 将通过改善 1 型糖尿病幼儿的健康结果而具有公共卫生意义。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Iterative development of a web-based intervention for families of young children with type 1 diabetes: DIPPer Academy.
针对 1 型糖尿病幼儿家庭的基于网络的干预措施的迭代开发:DIPPer Academy。
- DOI:
- 发表时间:2019-03
- 期刊:
- 影响因子:0
- 作者:Marker, Arwen M;Monzon, Alexandra D;Goggin, Kathy J;Clements, Mark A;Patton, Susana R
- 通讯作者:Patton, Susana R
Are we there yet? Advanced technologies for young children with type 1 diabetes: comment in response to "Type 1 diabetes mellitus management in young children: implementation of current technologies".
我们到了吗?
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:3.6
- 作者:Clements, Mark A;Patton, Susana R;McDonough, Ryan J;Artman, Michael
- 通讯作者:Artman, Michael
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eve-Lynn Nelson其他文献
Eve-Lynn Nelson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eve-Lynn Nelson', 18)}}的其他基金
Health Equity and Rural Education (HERE!) Clinical Trial: A Healthcare-Community Partnership Leveraging School-Based Community Health Workers to Improve Student Attendance
健康公平和农村教育(这里!)临床试验:利用学校社区卫生工作者提高学生出勤率的医疗保健社区合作伙伴关系
- 批准号:
10921332 - 财政年份:2023
- 资助金额:
$ 101.93万 - 项目类别:
相似国自然基金
内蒙古自治区5岁以下儿童死亡状况研究
- 批准号:81760591
- 批准年份:2017
- 资助金额:11.0 万元
- 项目类别:地区科学基金项目
基于LiST模型的西藏自治区孕产妇和儿童健康干预效果预测及策略研究
- 批准号:71603007
- 批准年份:2016
- 资助金额:17.0 万元
- 项目类别:青年科学基金项目
3-5岁幼儿说谎行为的发展及其影响因素的追踪研究
- 批准号:31400892
- 批准年份:2014
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
云南省汉族和彝族50岁以上人群原发性青光眼5年随访研究
- 批准号:81371016
- 批准年份:2013
- 资助金额:70.0 万元
- 项目类别:面上项目
5-6岁儿童被动吸烟随机对照干预研究
- 批准号:81273089
- 批准年份:2012
- 资助金额:65.0 万元
- 项目类别:面上项目
相似海外基金
Neuroimaging and Neurocognitive Markers of Brain Injury in Young Children with Sickle Cell Disease
镰状细胞病幼儿脑损伤的神经影像学和神经认知标志物
- 批准号:
10636709 - 财政年份:2023
- 资助金额:
$ 101.93万 - 项目类别:
Establishing the role of OCRL as a novel ciliary gene in weight regulation in human and murine models
建立 OCRL 作为新型纤毛基因在人类和小鼠模型体重调节中的作用
- 批准号:
10528081 - 财政年份:2022
- 资助金额:
$ 101.93万 - 项目类别:
Neuroimaging, Neurocognitive, and Plasma Protein Markers of Brain Injury in Young Children with Sickle Cell Disease
镰状细胞病幼儿脑损伤的神经影像学、神经认知和血浆蛋白标志物
- 批准号:
10281597 - 财政年份:2021
- 资助金额:
$ 101.93万 - 项目类别:
Preventing Obesity through Intervention during Infancy
通过婴儿期干预预防肥胖
- 批准号:
10400350 - 财政年份:2021
- 资助金额:
$ 101.93万 - 项目类别:
Neuroimaging, Neurocognitive, and Plasma Protein Markers of Brain Injury in Young Children with Sickle Cell Disease
镰状细胞病幼儿脑损伤的神经影像学、神经认知和血浆蛋白标志物
- 批准号:
10470928 - 财政年份:2021
- 资助金额:
$ 101.93万 - 项目类别: